Traumatic Optic Neuropathy Treatment Trial (TONTT)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

February 28, 2017

Conditions
Traumatic Optic Neuropathy
Interventions
DRUG

Recombinant human erythropoietin (EPO)

4000 units per vial

OTHER

Observation

Just observation

DRUG

Methyl prednisolone

250 mg every 6 hours for 3 days.

Trial Locations (3)

1467744814

Iran University of Medical Sciences, Tehran

Unknown

Shiraz University of Medical Sciences, Shiraz

Beheshti University of Medical Sciences, Tehran

All Listed Sponsors
collaborator

Iran University of Medical Sciences

OTHER

collaborator

Mashhad University of Medical Sciences

OTHER

collaborator

Shahid Beheshti University of Medical Sciences

OTHER

lead

Tehran University of Medical Sciences

OTHER

NCT01783847 - Traumatic Optic Neuropathy Treatment Trial (TONTT) | Biotech Hunter | Biotech Hunter